US 12,168,039 B2
Anti-inflammatory peptides and composition comprising the same
Sang Jae Kim, Seoul (KR); Kyung Hee Kim, Seoul (KR); Kyu-Yong Lee, Seoul (KR); Seong-Ho Koh, Seoul (KR); Hyun-Hee Park, Seoul (KR); Sung Jin Huh, Seoul (KR); Woo Jin Lee, Seoul (KR); and Bum Joon Kim, Daejeon (KR)
Assigned to GemVax & KAEL CO., LTD., Daejeon (KR)
Filed by GemVax & KAEL CO., LTD., Daejeon (KR)
Filed on Aug. 9, 2023, as Appl. No. 18/447,049.
Application 18/447,049 is a division of application No. 17/835,278, filed on Jun. 8, 2022, granted, now 11,857,607, issued on Jan. 2, 2024.
Application 17/835,278 is a division of application No. 17/080,653, filed on Oct. 26, 2020, granted, now 11,369,665, issued on Jun. 28, 2022.
Application 17/080,653 is a division of application No. 16/025,352, filed on Jul. 2, 2018, granted, now 10,960,056, issued on Mar. 30, 2021.
Application 16/025,352 is a division of application No. 15/343,502, filed on Nov. 4, 2016, granted, now 10,039,811, issued on Aug. 7, 2018.
Application 15/343,502 is a division of application No. 14/400,291, granted, now 9,540,419, issued on Jan. 10, 2017, previously published as PCT/EP2013/059460, filed on May 7, 2013.
Claims priority of application No. 10-2012-0050529 (KR), filed on May 11, 2012; application No. 10-2012-0050533 (KR), filed on May 11, 2012; application No. 10-2012-0071989 (KR), filed on Jul. 2, 2012; application No. 10-2012-0104144 (KR), filed on Sep. 12, 2012; application No. 10-2012-0104207 (KR), filed on Sep. 19, 2012; and application No. PCT/EP2013/055329 (WO), filed on Mar. 15, 2013.
Prior Publication US 2024/0000902 A1, Jan. 4, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/10 (2006.01); A23L 33/18 (2016.01); A61K 8/64 (2006.01); A61K 38/17 (2006.01); A61K 38/45 (2006.01); A61P 19/02 (2006.01); A61P 37/00 (2006.01); A61P 37/06 (2006.01); A61Q 19/00 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C12N 9/02 (2006.01); A61K 38/00 (2006.01)
CPC A61K 38/45 (2013.01) [A23L 33/18 (2016.08); A61K 8/64 (2013.01); A61Q 19/00 (2013.01); C07K 7/08 (2013.01); C07K 14/4703 (2013.01); C12N 9/0069 (2013.01); C12N 9/0083 (2013.01); C12Y 113/11 (2013.01); C12Y 114/99001 (2013.01); C12Y 207/07049 (2013.01); A23V 2002/00 (2013.01); A61K 38/00 (2013.01); Y02A 50/30 (2018.01)] 8 Claims
 
1. A method for treating autoimmune disease comprising administering to a subject in need thereof a composition comprising the isolated peptide of SEQ ID NO: 1, wherein the autoimmune disease is thyroiditis, lupus, Goodpasture's syndrome, allograft rejection, graft versus host disease, or diabetes.